Dianthus Therapeutics, Inc.

Biotechnology company · Waltham, Massachusetts, United States

Dianthus Therapeutics, Inc. is a biotechnology company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $100 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Dianthus Therapeutics at a glance

Typebiotechnology company

HeadquartersWaltham, Massachusetts, United States

Earliest incorporation on record2019

SEC CIK1783732

What does Dianthus Therapeutics do?

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $100 million sold (2022).

Frequently asked questions about Dianthus Therapeutics

Where is Dianthus Therapeutics headquartered?

Dianthus Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.

What does Dianthus Therapeutics do?

Dianthus Therapeutics, Inc. is a biotechnology company.

When was Dianthus Therapeutics founded?

The earliest incorporation on record for Dianthus Therapeutics, Inc. is in 2019, according to public company registers.

Similar companies

Repligen CorpWaltham, Massachusetts, United States
TScan Therapeutics, Inc.Waltham, Massachusetts, United States
La Jolla Pharmaceutical CoWaltham, Massachusetts, United States
MINERVA BIOTECHNOLOGIES CorpWaltham, Massachusetts, United States
Viridian Therapeutics, Inc.Waltham, Massachusetts, United States
Pyramid Biosciences, Inc.Waltham, Massachusetts, United States
Mythic Therapeutics, Inc.Waltham, Massachusetts, United States
Solarea Bio, Inc.Waltham, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences